Plato Investment Management Ltd raised its holdings in Lam Research Co. (NASDAQ:LRCX – Free Report) by 3.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,566 shares of the semiconductor company’s stock after buying an additional 191 shares during the quarter. Plato Investment Management Ltd’s holdings in Lam Research were worth $4,538,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Fortitude Family Office LLC grew its holdings in shares of Lam Research by 16.7% during the second quarter. Fortitude Family Office LLC now owns 63 shares of the semiconductor company’s stock worth $67,000 after buying an additional 9 shares in the last quarter. Thomasville National Bank boosted its position in Lam Research by 1.5% during the second quarter. Thomasville National Bank now owns 812 shares of the semiconductor company’s stock worth $865,000 after acquiring an additional 12 shares during the last quarter. U.S. Capital Wealth Advisors LLC grew its stake in Lam Research by 3.7% during the 2nd quarter. U.S. Capital Wealth Advisors LLC now owns 335 shares of the semiconductor company’s stock valued at $357,000 after acquiring an additional 12 shares in the last quarter. Ignite Planners LLC raised its holdings in Lam Research by 2.8% in the 2nd quarter. Ignite Planners LLC now owns 445 shares of the semiconductor company’s stock valued at $484,000 after acquiring an additional 12 shares during the last quarter. Finally, RFP Financial Group LLC lifted its stake in Lam Research by 52.2% in the 2nd quarter. RFP Financial Group LLC now owns 35 shares of the semiconductor company’s stock worth $37,000 after purchasing an additional 12 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on LRCX shares. Cantor Fitzgerald restated a “neutral” rating and issued a $100.00 price target on shares of Lam Research in a research report on Thursday, October 24th. Needham & Company LLC reaffirmed a “buy” rating and issued a $100.00 target price on shares of Lam Research in a research note on Thursday, October 24th. Deutsche Bank Aktiengesellschaft reduced their price target on Lam Research from $110.00 to $95.00 and set a “buy” rating on the stock in a report on Thursday, August 1st. Citigroup dropped their price objective on shares of Lam Research from $99.00 to $89.30 and set a “buy” rating for the company in a report on Monday, September 16th. Finally, UBS Group reduced their target price on shares of Lam Research from $125.00 to $115.00 and set a “buy” rating on the stock in a research note on Thursday, September 12th. Seven equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, Lam Research has a consensus rating of “Moderate Buy” and an average target price of $97.03.
Insider Buying and Selling at Lam Research
In other news, CAO Christina Correia sold 647 shares of the company’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $817.51, for a total transaction of $528,928.97. Following the sale, the chief accounting officer now owns 4,267 shares of the company’s stock, valued at approximately $3,488,315.17. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.29% of the stock is currently owned by corporate insiders.
Lam Research Trading Down 2.4 %
LRCX opened at $73.85 on Thursday. The company has a quick ratio of 1.74, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. The firm has a market cap of $95.02 billion, a P/E ratio of 23.87, a P/E/G ratio of 1.20 and a beta of 1.48. Lam Research Co. has a 52 week low of $68.39 and a 52 week high of $113.00. The business has a fifty day simple moving average of $77.42 and a 200-day simple moving average of $88.34.
Lam Research (NASDAQ:LRCX – Get Free Report) last released its earnings results on Wednesday, October 23rd. The semiconductor company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.05. The company had revenue of $4.17 billion during the quarter, compared to the consensus estimate of $4.06 billion. Lam Research had a return on equity of 50.60% and a net margin of 26.02%. Lam Research’s revenue was up 19.7% compared to the same quarter last year. During the same period in the previous year, the company posted $6.85 EPS. On average, equities analysts expect that Lam Research Co. will post 3.52 earnings per share for the current year.
Lam Research Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 8th. Shareholders of record on Wednesday, December 11th will be issued a dividend of $0.23 per share. The ex-dividend date of this dividend is Wednesday, December 11th. This represents a $0.92 dividend on an annualized basis and a yield of 1.25%. Lam Research’s dividend payout ratio (DPR) is presently 29.74%.
Lam Research Company Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Read More
- Five stocks we like better than Lam Research
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- What Are Dividends? Buy the Best Dividend Stocks
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
- 10 Best Airline Stocks to Buy
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.